Moderate-to-severe sleep apnea is associated with elevated amino acid levels in peripheral blood Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
C-reactive protein (CRP) levels in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 1046-1048 Year: 2012
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007